These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28387827)

  • 21. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
    Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF
    J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
    Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M
    Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypercholesterolaemia: a pressing issue for European health care.
    Brice P; Burton H; Edwards CW; Humphries SE; Aitman TJ
    Atherosclerosis; 2013 Dec; 231(2):223-6. PubMed ID: 24267231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening.
    Marks D; Thorogood M; Neil HA; Wonderling D; Humphries SE
    J Public Health Med; 2003 Mar; 25(1):47-52. PubMed ID: 12669918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families.
    Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J
    Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia.
    Martin AC; Hooper AJ; Norman R; Nguyen LT; Burnett JR; Bell DA; Brett T; Garton-Smith J; Pang J; Nowak KJ; Watts GF
    J Paediatr Child Health; 2022 Feb; 58(2):281-287. PubMed ID: 34387892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.
    Villa G; Lothgren M; Kutikova L; Lindgren P; Gandra SR; Fonarow GC; Sorio F; Masana L; Bayes-Genis A; Hout BV
    Clin Ther; 2017 Apr; 39(4):771-786.e3. PubMed ID: 28366593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia.
    Loh WJ; Pang J; Chakraborty A; Ward NC; Chan DC; Hooper AJ; Bell DA; Burnett JR; Martin AC; Watts GF
    J Clin Lipidol; 2024; 18(1):e33-e37. PubMed ID: 38040538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
    Talmud PJ; Shah S; Whittall R; Futema M; Howard P; Cooper JA; Harrison SC; Li K; Drenos F; Karpe F; Neil HA; Descamps OS; Langenberg C; Lench N; Kivimaki M; Whittaker J; Hingorani AD; Kumari M; Humphries SE
    Lancet; 2013 Apr; 381(9874):1293-301. PubMed ID: 23433573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients.
    Hendy LE; Spees LP; Tak C; Carpenter DM; Thomas KC; Roberts MC
    Atherosclerosis; 2024 Jun; 393():117541. PubMed ID: 38677159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evaluation of cascade testing for familial hypercholesterolemia.
    Morris JK; Wald DS; Wald NJ
    Am J Med Genet A; 2012 Jan; 158A(1):78-84. PubMed ID: 22139944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
    Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
    Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.
    Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H
    BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States.
    Spencer SJ; Jones LK; Guzauskas GF; Hao J; Williams MS; Peterson JF; Veenstra DL
    J Clin Lipidol; 2022; 16(5):667-675. PubMed ID: 35961838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a).
    Chakraborty A; Pang J; Chan DC; Ellis KL; Hooper AJ; Bell DA; Burnett JR; Moses EK; Watts GF
    Atherosclerosis; 2022 May; 349():219-226. PubMed ID: 34862044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.